XIENCE XPEDITION Adverse Events: FDA MAUDE Data
ABBOTT VASCULAR INC. · Coronary Drug-Eluting Stent · First cleared Sep 2016
Total Reports
2,193
Reports (30d)
8
Active Signals
0
Open Recalls
0
What the reports describe · Claripulse analysis
Most commonly reported problems
Distal Edge Dissection Post-Implant
additional information, information provided, skypoint, xience skypoint, provided procedure
8
reports
Polymer-Free Stent Safety Outcomes
outcomes, polymer, article, patients, years
4
reports
Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.
Evidence
Related research
Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents
Salma Bibi, et al. · Frontiers in Pharmacology · 2022
Procedural Safety and Long-Term Clinical Outcomes in Patients Receiving Ultra-Long Everolimus-Eluting Stent: A Single-Center Real-World Experience
Nagendra Boopathy Senguttuvan, et al. · Cardiology Research · 2022
Safety and efficacy of 48 mm Xience Xpedition everolimus‐eluting stent for the treatment of long coronary lesions
Alexandre Gautier, et al. · Catheterization and Cardiovascular Interventions · 2022
Procedural and One-Year Clinical Outcomes of Long 48 mm Xience Xpedition Everolimus-Eluting Stent in Complex Long Diffuse Coronary Artery Lesions
Fu‐Chih Hsiao, et al. · The Journal of invasive cardiology/The journal of invasive cardiology · 2022
Citations indexed from PubMed.
Keep exploring
Related devices in Coronary
Perclose ProGlide
ABBOTT VASCULAR INC. · 24,635 reports
Perclose ProStyle
ABBOTT VASCULAR INC. · 19,655 reports
PERCLOSE
ABBOTT VASCULAR INC. · 10,082 reports
Angio-Seal
TERUMO MEDICAL CORPORATION · 6,727 reports
SYNERGY
BOSTON SCIENTIFIC CORPORATION · 6,095 reports
Resolute Onyx
MEDTRONIC, INC. · 4,494 reports
Want automated safety signal detection?
Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.
Get Early AccessUnderstanding this data